Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Non-squamous NSCLC 1Non Small Cell Lung 1Lung Neoplasms 1HER2 Insertion Mutation Positive Advanced NSCLC 1

Interventions

pyrotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HER2 Insertion Mutation Positive Advanced NSCLC × pyrotinib × Thoracic × Clear all
NCT04144569 2024-09-19

PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC

Hunan Province Tumor Hospital

Phase 2 Recruiting
30 enrolled
Thoracic

HER2 Insertion Mutation Positive Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡